Mocetinostat

Mocetinostat (MGCD0103) is a benzamide histone deacetylase inhibitor undergoing clinical trials for treatment of various cancers including follicular lymphoma, Hodgkin`s lymphoma and acute myelogenous leukemia. One clinical trial (for refractory follicular lymphoma) was temporarily put on hold due to cardiac problems but resumed recruiting in 200....
Found on http://en.wikipedia.org/wiki/Mocetinostat

mocetinostat

A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called MGCD0103.
Found on http://www.cancer.gov/dictionary?expand=M
No exact match found